Simplex Trading’s Takeda Pharmaceutical TAK Stock Holding History

Simplex Trading’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-5,146	Closed	-$85.2K	–	10286
2026 Q1	$95.3K	Buy	+5,146	New	+$90.3K	﹤0.01%	5139
2021 Q4	–	Sell	-28,449	Closed	-$399K	–	11399
2021 Q3	$480K	Sell	28,449 -3,343	-11%	-$56.1K	﹤0.01%	4164
2021 Q2	$535K	Buy	31,792 +14,767	+87%	+$251K	﹤0.01%	4051
2021 Q1	$310K	Buy	17,025 +14,425	+555%	+$260K	﹤0.01%	4105
2020 Q4	$47K	Sell	2,600 -2,000	-43%	-$35.1K	﹤0.01%	6258
2020 Q3	$82K	Hold	4,600	–	–	﹤0.01%	5115
2020 Q2	$82K	Sell	4,600 -10,148	-69%	-$182K	﹤0.01%	5008
2020 Q1	$223K	Buy	+14,748	New	+$267K	﹤0.01%	3467
2019 Q4	–	Sell	-2,166	Closed	-$41.4K	–	7951
2019 Q3	$0	Buy	+2,166	New	+$37.5K	﹤0.01%	7872

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Simplex Trading's TAK Position: Q2 2026 in Review

Simplex Trading sold out of Takeda Pharmaceutical (TAK) in Q2 2026, closing a stake of 5,146 shares — an estimated $85.2K sold.

Simplex Trading first reported a position in TAK in Q3 2019 and held it in 9 quarters. The position peaked at $535K in Q2 2021. 379 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Simplex Trading reported no remaining Takeda Pharmaceutical position as of Q2 2026 after selling out during the quarter.
Simplex Trading sold 5,146 Takeda Pharmaceutical shares in Q2 2026, an estimated $85.2K.
Simplex Trading first reported a position in Takeda Pharmaceutical in Q3 2019 and held it in 9 quarters.
Simplex Trading's Takeda Pharmaceutical position peaked at $535K in Q2 2021.
379 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.